Relyea Zuckerberg Hanson LLC Boosts Stock Position in Oracle Corporation $ORCL

Relyea Zuckerberg Hanson LLC lifted its stake in Oracle Corporation (NYSE:ORCLFree Report) by 1.0% in the 2nd quarter, Holdings Channel.com reports. The firm owned 10,561 shares of the enterprise software provider’s stock after purchasing an additional 108 shares during the period. Relyea Zuckerberg Hanson LLC’s holdings in Oracle were worth $2,309,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Brighton Jones LLC raised its holdings in shares of Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after acquiring an additional 100,494 shares during the period. Revolve Wealth Partners LLC increased its position in Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares during the last quarter. Sivia Capital Partners LLC raised its stake in Oracle by 5.0% during the first quarter. Sivia Capital Partners LLC now owns 3,580 shares of the enterprise software provider’s stock worth $501,000 after purchasing an additional 171 shares during the period. UMB Bank n.a. boosted its holdings in Oracle by 1.0% in the 1st quarter. UMB Bank n.a. now owns 215,074 shares of the enterprise software provider’s stock valued at $30,069,000 after purchasing an additional 2,217 shares during the last quarter. Finally, Whitaker Myers Wealth Managers LTD. acquired a new position in Oracle in the 1st quarter valued at about $515,000. Institutional investors and hedge funds own 42.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ORCL. DA Davidson lifted their price target on shares of Oracle from $220.00 to $300.00 and gave the company a “neutral” rating in a research report on Wednesday, September 10th. Jefferies Financial Group raised their target price on Oracle from $270.00 to $360.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Scotiabank reaffirmed an “outperform” rating on shares of Oracle in a research note on Wednesday, September 10th. Sanford C. Bernstein raised their price objective on Oracle from $363.00 to $364.00 and gave the stock an “outperform” rating in a research report on Friday, September 26th. Finally, Raymond James Financial restated a “strong-buy” rating on shares of Oracle in a report on Wednesday, June 18th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $304.71.

Check Out Our Latest Stock Report on Oracle

Insider Buying and Selling

In other news, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction dated Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares in the company, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William G. Parrett sold 11,500 shares of the business’s stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director directly owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This represents a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 104,314 shares of company stock worth $31,272,223 over the last 90 days. 40.90% of the stock is currently owned by company insiders.

Oracle Stock Performance

NYSE ORCL opened at $286.23 on Monday. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The company has a market cap of $815.99 billion, a P/E ratio of 66.26, a P/E/G ratio of 3.08 and a beta of 1.53. The stock has a 50-day moving average of $262.53 and a two-hundred day moving average of $205.85. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle’s dividend payout ratio is 46.30%.

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.